CompletedPhase 3NCT00047723

Minocycline to Treat Amyotrophic Lateral Sclerosis

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Principal Investigator
Paul H. Gordon, M.D.,
Associate Medical Director, Eleanor and Lou Gehrig MDA/ALS Center, Columbia University Medical Center
Intervention
minocycline(drug)
Enrollment
400 enrolled
Eligibility
21-85 years · All sexes
Timeline
20032007

Study locations (30)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00047723 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials